Macular degeneration is the leading cause of blindness in people over age 60.
Now, a drug manufacturer is close to getting a green light from the FDA for a new drug that could help treat the wet version of the disease. The new drug is called Eylea.
Even though an FDA advisory panel recommended approval, a final decision is not expected until November.
Dan Van Plew said, "You don't just make it and send it. There's tremendous testing, there are lots of labs here. There's a lot of science that goes into making sure it's safe to use, to make sure it's of the right strength, of the right purity."
Eylea is given by injection into the eye, once every 8 weeks. That may sound terrible, but that's a big improvement over drugs already on the market that require injections every month.
Copyright 2011 KCBD. All rights reserved